157 related articles for article (PubMed ID: 17637740)
1. Cytotoxic drug-induced, p53-mediated upregulation of caspase-8 in tumor cells.
Ehrhardt H; Häcker S; Wittmann S; Maurer M; Borkhardt A; Toloczko A; Debatin KM; Fulda S; Jeremias I
Oncogene; 2008 Jan; 27(6):783-93. PubMed ID: 17637740
[TBL] [Abstract][Full Text] [Related]
2. Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity.
Liu X; Yue P; Khuri FR; Sun SY
Cancer Res; 2005 Oct; 65(20):9169-75. PubMed ID: 16230375
[TBL] [Abstract][Full Text] [Related]
3. Trichostatin A sensitizes human ovarian cancer cells to TRAIL-induced apoptosis by down-regulation of c-FLIPL via inhibition of EGFR pathway.
Park SJ; Kim MJ; Kim HB; Sohn HY; Bae JH; Kang CD; Kim SH
Biochem Pharmacol; 2009 Apr; 77(8):1328-36. PubMed ID: 19426671
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitors cooperate with IFN-gamma to restore caspase-8 expression and overcome TRAIL resistance in cancers with silencing of caspase-8.
Häcker S; Dittrich A; Mohr A; Schweitzer T; Rutkowski S; Krauss J; Debatin KM; Fulda S
Oncogene; 2009 Sep; 28(35):3097-110. PubMed ID: 19597472
[TBL] [Abstract][Full Text] [Related]
5. Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosis.
Geserick P; Drewniok C; Hupe M; Haas TL; Diessenbacher P; Sprick MR; Schön MP; Henkler F; Gollnick H; Walczak H; Leverkus M
Oncogene; 2008 May; 27(22):3211-20. PubMed ID: 18084329
[TBL] [Abstract][Full Text] [Related]
6. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.
Shin DY; Kim GY; Kim ND; Jung JH; Kim SK; Kang HS; Choi YH
Oncol Rep; 2008 Feb; 19(2):517-26. PubMed ID: 18202802
[TBL] [Abstract][Full Text] [Related]
7. TRAIL-induced survival and proliferation of SCLC cells is mediated by ERK and dependent on TRAIL-R2/DR5 expression in the absence of caspase-8.
Belyanskaya LL; Ziogas A; Hopkins-Donaldson S; Kurtz S; Simon HU; Stahel R; Zangemeister-Wittke U
Lung Cancer; 2008 Jun; 60(3):355-65. PubMed ID: 18093694
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of proteasome activity sensitizes human granulosa tumor cells to TRAIL-induced cell death.
Woods DC; Liu HK; Nishi Y; Yanase T; Johnson AL
Cancer Lett; 2008 Feb; 260(1-2):20-7. PubMed ID: 18031928
[TBL] [Abstract][Full Text] [Related]
9. Role of caspase 8 as a determinant in trail sensitivity of neuroblastoma cell lines.
Tong H; Lu C; Yang Y; Zhang J; Zhang J
Pediatr Hematol Oncol; 2009 Nov; 26(8):549-59. PubMed ID: 19954364
[TBL] [Abstract][Full Text] [Related]
10. The pleiotropic effect of TRAIL on tumor-like synovial fibroblasts from rheumatoid arthritis patients is mediated by caspases.
Audo R; Combe B; Coulet B; Morel J; Hahne M
Cell Death Differ; 2009 Sep; 16(9):1227-37. PubMed ID: 19407827
[TBL] [Abstract][Full Text] [Related]
11. Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis.
Siddiqui IA; Malik A; Adhami VM; Asim M; Hafeez BB; Sarfaraz S; Mukhtar H
Oncogene; 2008 Mar; 27(14):2055-63. PubMed ID: 17998943
[TBL] [Abstract][Full Text] [Related]
12. Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand.
Yasuda T; Yoshida T; Goda AE; Horinaka M; Yano K; Shiraishi T; Wakada M; Mizutani Y; Miki T; Sakai T
Mol Cancer Res; 2008 Dec; 6(12):1852-60. PubMed ID: 19074830
[TBL] [Abstract][Full Text] [Related]
13. The evaluation of gastric cancer sensitivity to 5-FU/CDDP in terms of induction of apoptosis: time- and p53 expression-dependency of anti-cancer drugs.
Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S
Oncol Rep; 2005 Sep; 14(3):609-15. PubMed ID: 16077963
[TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation.
Kim EH; Yoon MJ; Kim SU; Kwon TK; Sohn S; Choi KS
Cancer Res; 2008 Jan; 68(1):266-75. PubMed ID: 18172319
[TBL] [Abstract][Full Text] [Related]
15. Andrographolide enhances 5-fluorouracil-induced apoptosis via caspase-8-dependent mitochondrial pathway involving p53 participation in hepatocellular carcinoma (SMMC-7721) cells.
Yang L; Wu D; Luo K; Wu S; Wu P
Cancer Lett; 2009 Apr; 276(2):180-8. PubMed ID: 19097688
[TBL] [Abstract][Full Text] [Related]
16. Important role of caspase-8 for chemosensitivity of ALL cells.
Ehrhardt H; Wachter F; Maurer M; Stahnke K; Jeremias I
Clin Cancer Res; 2011 Dec; 17(24):7605-13. PubMed ID: 22010212
[TBL] [Abstract][Full Text] [Related]
17. Enhanced effect of IFNgamma on the induced apoptosis of neuroblastoma cells by cytotoxic drugs.
Tong HX; Lu CW; Zhang JH; Zhang JH
Pediatr Hematol Oncol; 2008 Sep; 25(6):549-58. PubMed ID: 18728974
[TBL] [Abstract][Full Text] [Related]
18. Wild type p53 increased chemosensitivity of drug-resistant human hepatocellular carcinoma Bel7402/5-FU cells.
Li YX; Lin ZB; Tan HR
Acta Pharmacol Sin; 2004 Jan; 25(1):76-82. PubMed ID: 14704126
[TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis in osteogenic sarcoma cells by combination of tumor necrosis factor-related apoptosis inducing ligand and chemotherapeutic agents.
Sun J; Fu ZM; Fang CQ; Li JH
Chin Med J (Engl); 2007 Mar; 120(5):400-4. PubMed ID: 17376311
[TBL] [Abstract][Full Text] [Related]
20. A mitochondrial block and expression of XIAP lead to resistance to TRAIL-induced apoptosis during progression to metastasis of a colon carcinoma.
Ndozangue-Touriguine O; Sebbagh M; Mérino D; Micheau O; Bertoglio J; Bréard J
Oncogene; 2008 Oct; 27(46):6012-22. PubMed ID: 18560353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
